Society Leadership Changes Hands

	Who We Are
	Governance
	Infinity Circle
	Career Opportunities

Home > About HRS > Governance

Society Leadership Changes Hands

On May 15, 2009 during the Presidents’ Reception at Heart Rhythm 2009, N.A. Mark Estes III, MD, FHRS, passed the ceremonial gavel to Richard Page, MD, FHRS, the new President of the Heart Rhythm Society. The following article was originally published in the May 16, 2009 issue of Heart Rhythm Daily, the official publication of the 30th Annual Scientific Sessions.

Heart Rhythm Society Leadership Changes Hands

N.A. Mark Estes III, MD, FHRS passes the ceremonial gavel to 2009-2010 Society President Richard L. Page, MD, FHRS

N.A. Mark Estes III, MD, FHRS (right) passed the ceremonial gavel to 2009-2010 Society President Richard L. Page, MD, FHRS on May 15, 2009 at the Presidents’ Reception during Heart Rhythm 2009.

On May 15, 2009 during the Presidents’ Reception at Heart Rhythm 2009, N.A. Mark Estes III, MD, FHRS, passed the ceremonial gavel to Richard Page, MD, FHRS, the new President of the Heart Rhythm Society.

[See full listing of the Society's 2009-2010 Board of Trustees]

Dr. Estes is Chief of the Cardiac Arrhythmia Center of the New England Medical Center Hospital in Boston, and Professor of Medicine at Tufts University School of Medicine. In addition to serving as the Society’s Past President, he is the Chairman of the Heart Rhythm Society Strategic Planning Task Force, Co-director of the Board Review Course in Cardiac Electrophysiology and an Associate Editor of HeartRhythm Journal.

Author of more than 350 publications including original reports, reviews, chapters and four books, Dr. Estes’ research interests are focused on prediction and prevention of sudden cardiac arrest and arrhythmias in athletes. He was one of the lead authors in the Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation Trial (DEFINITE), which found that patients with nonischemic cardiomyopathy who received ICD therapy had significantly reduced sudden death from arrhythmia with an associated trend toward reduction in all-cause mortality compared with standard medical therapy.

Dr. Estes’ term as President of the Society saw the development of a new Strategic Plan, which will guide the Society for the next several years.

He passes the Presidency on to Dr. Page, who has been a member of the Heart Rhythm Society since 1990. During this time he has held numerous volunteer positions, most recently as President-elect. [Read letter from Dr. Page to Heart Rhythm Society members and other heart rhythm professionals.]

Dr. Page holds the Robert A. Bruce Endowed Chair in Cardiovascular Research and is Professor and Head of the Division of Cardiology at the University of Washington School of Medicine in Seattle.

Dr. Page’s areas of clinical expertise include atrial fibrillation, sudden cardiac death and syncope. He is also known for his research in asymptomatic atrial fibrillation, drug therapy for atrial fibrillation, and automated external defibrillators. He has been widely published in leading journals such as the New England Journal of Medicine, JAMA, the Annals of Internal Medicine and HeartRhythm. He serves on the editorial boards for the American Heart Journal, the American Journal of Cardiology, PACE, the Journal of Cardiovascular Electrophysiology, HeartRhythm and Circulation.

Dr. Page has served as a standing member of the Circulatory System Devices Panel of the Medical Devices Advisory Committee at the FDA and has also chaired committees for the American Heart Association and the American College of Cardiology Foundation.